Uricostatic Effect of Allopurinol in the Allantoxanamide-Treated Rat: A New Method for Evaluating Antiuricopathic Drugs-Reference-Cited by-同舟云学术

Uricostatic Effect of Allopurinol in the Allantoxanamide-Treated Rat: A New Method for Evaluating Antiuricopathic Drugs

Published:1984 Issue: Volume: Page:175-178
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Hropot Max,Muschaweck Roman,Klaus Erik

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4684-4553-4_33

Reference4 articles.

1. W. J. Johnson and André Chartrand, Allantoxanamide: A potent new uricase inhibitor in vivo, Life Sciences, 23: 2239 (1978)

2. M. Hropot, F. Sörgel, B. v. Kerékjârtó, H. J. Lang, and R. Muschaweck, Pharmacological effects of 1,3,5-triazines and their excretion characteristics in the rat, Purine Metabolism in Man-III, 122A: 269, Plenum Press, New York (1980)

3. R. D. Smith, A. D. Essenburg, and H. R. Kaplan, The oxonatepretreated rat as a model for evaluating hyperuricemic effects of antihypertensive drugs, Clin. exp. Hypertens. 1: 487 (1979)

4. H. Iwata, I. Yamamoto, I. Ghoda, E. K. Morita, M. Nakamuro, and K. Sumi, Potent competitive uricase inhibitors 2,8-diazahypoxanthine and related compounds, Biochem. Pharmacol. 22: 2237 (1973)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uricosuric and Hypo-Uricemic Activity;Drug Discovery and Evaluation: Pharmacological Assays;2016

2. Renal System in Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2013

3. Safety Pharmacology of Drugs for the Urinary Tract;Drug Discovery and Evaluation;2006

4. Activity on urinary tract1;Drug Discovery and Evaluation;2002

5. Renal activity;Drug Discovery and Evaluation;1997